Roivant Sciences Ltd.近日发布了关于持久性治疗效果和六个月无治疗缓解期的临床数据,这些数据显示出改变未受控制Graves病患者治疗范式的潜力。
Roivant Sciences Ltd.近日发布了关于持久性治疗效果和六个月无治疗缓解期的临床数据,这些数据显示出改变未受控制Graves病患者治疗范式的潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.